Flolan 1,5 mg; forsyningsvanskelighed
Safety Classified by Officially
Markedsføringen af Flolan 1,5 mg pulver og solvens til infusionsvæske, opløsning fra GlaxoSmithKline Pharma A/S vil ophøre.
Produkt: Flolan 1,5 mg pulver og solvens til infusionsvæske, opløsning
Aktivt stof: Epoprostenol (epoprostenolnatrium)
Forventet periode: Fra slut december 2027
Yderligere information: Permanent markedsophør
This is an extract. The publication continues at the source.
Source: Lægemiddelstyrelsen.
Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/meddelelser-om-forsyning-af-medicin/human-2026/flolan-1,5-mg-forsyningsvanskelighed/
Officially imported this from Lægemiddelstyrelsen’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Lægemiddelstyrelsen — imported from official source
- Official source
- https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
- Imported
- October 30, 2026 15:32
- Versions
- 1 recorded
- Identity
-
4FA3C45C22004EA3A6651416FEFD17F4